The Cost-Effectiveness of Biologic Dmards in Patients With Severe or Mild-To-Severe Rheumatoid Arthritis After Conventional Dmards.

Wailoo, A J; Stevenson, M; Tosh, J; Hernández, M; Stevens, J W; Archer, R; Simpson, E; Everson, Hock E; Scott, D; Young, A; Paisley, S; Williams, K

Wailoo, A J; Stevenson, M; Tosh, J; Hernández, M; Stevens, J W; Archer, R; Simpson, E; Everson, Hock E; Scott, D; Young, A; Paisley, S; Williams, K.

Afiliación

Wailoo AJ; NICE Decision Support Uni, Sheffield, UK.
Stevenson M; University of Sheffield, Sheffield, UK.
Tosh J; University of Sheffield, Sheffield, UK.
Hernández M; University of Sheffield, Sheffield, UK.
Stevens JW; University of Sheffield, Sheffield, UK.
Archer R; University of Sheffield, Sheffield, UK.
Simpson E; University of Sheffield, Sheffield, UK.
Everson HE; University of Sheffield, Sheffield, UK.
Scott D; KCL, London, UK.
Young A; adam. young@nhs. net, Heertford, UK.
Paisley S; The University of Sheffield, Sheffield, UK.
Williams K; The University of Sheffield, Sheffield, UK.

Value Health ; 17(7): A380, 2014 Nov.

Article en En | MEDLINE | ID: mdl-27200840

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google